Buds & Duds: Cannabis investors greeted with mixed bag; True Leaf, Canopy grow while Aurora and Charlotte's Web fall

True Leaf's subsidiary received its cultivation and sales license for its Lumby, BC facility

cannabis pot plants
Also moving on Monday were Heritage Cannabis, EuroLife Brands and Cardiol Therapeutics

Cannabis stocks were mixed on Monday amidst a flurry of news to kick off the week.

The North American Marijuana Index, which tracks the top cannabis stocks in the US and Canada, lost 0.6% at 122 points. Elsewhere, the Horizons Marijuana Life Sciences Index ETF inched 0.4% higher to C$9.52, while the OTCQX Cannabis retreated 2.5% at 461.3 points.


True Leaf Brands Inc (CSE:MJ) (OTCMKTS:TRLFF) revealed Monday that its subsidiary True Leaf Cannabis Inc has secured licenses from Health Canada to cultivate, process and sell cannabis for medical purposes from its 18,000-square-foot True Leaf Campus facility in Lumby, British Columbia.

The news sent the Canadian company’s shares 16.7% higher in Canada at C$0.14 and 5.6% higher over the counter at US$0.10.

Heritage Cannabis Holdings Corp (CSE:CANN) (OTCMKTS:HERTF) was also higher on Monday following news that its subsidiary CannaCure Corporation received approval from Health Canada to expand its Ontario extraction facility.

CannaCure’s Fort Erie facility’s extraction capabilities will be boosted by the expansion of three additional rooms as a result of the amended license granted by the Canadian cannabis regulator.

Shares of Heritage were 7.7% higher in Canada at C$0.28 and 8.2% higher over the counter at US$0.22.

EuroLife Brands Inc (CSE:EURO) (OTCMKTS: EURPF) saw double-digit gains in Canada after it expanded into Europe's hemp market with new stake in Germany, sending shares up 20% at C$0.06.

In large cap news, Canopy Growth Corporation (TSE:WEED) (NYSE:CGC) shares were up 3.4% in Toronto at C$25.30 and 3.2% in New York at US$19 after Health Canada granted the cannabis cultivator a license for its new beverage facility in Smith Falls, Ontario.


Pharmaceutical CBD producer Cardiol Therapeutics Inc (TSE:CRDL) (OTCMKTS:CRTPF) fell 3.6% in Toronto at C$3.22 and 2.1% on OTC markets at US$2.45 after its CEO commented on the US Drug Enforcement Agency’s decision to deschedule its supplier Purisys’s cannabinoid ingredients.

"This landmark decision underscores Cardiol's rationale for selecting Purisys to supply the API for our CardiolRx formulation and supports our unwavering commitment to produce the safest and most consistent cannabidiol formulations for patients who should not be exposed to THC,” said CEO David Elsley in a statement.

Also down on Monday was Charlotte’s Web Holdings Inc (TSE:CWEB) (OTCMKTS:CWBHF), which sank 6.1% in Toronto at C$13.14 and 6.4% over the counter at US$9.87 after announcing a C$66.3 million public offering.

Aurora Cannabis Inc (TSE:ACB) (NYSE:ACB) also fell on Monday, down 2.2% in Toronto and 3.3% in New York at C$3.50 and US$2.61 respectively. The cannabis grower converted 99% of its $C230 million debentures into 69 million shares.

Contact Angela at angela@proactiveinvestors.com

Follow her on Twitter @AHarmantas

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of True Leaf Brands Inc. named herein, including the promotion by the Company of True Leaf Brands Inc. in any Content on the Site, the Company...


Loop Insights getting ready to rumble as platform wallet being used by the...

Loop Insights (CVE: MTRX- OTCQB: RACMF) CEO Rob Anson joined Steve Darling from Proactive with big news that Loop's Wallet pass platform will engage global boxing fans during the WBC super-middleweight championship fight, featuring champion Saul "Canelo" Alvarez and challenger Avni...

23 hours, 50 minutes ago

3 min read